Interim report January – June 2009

Second quarter 2009 - The Group reported an operating loss of SEK 24 m (loss: 8) - After taxes, the Group’s loss was SEK 18 m (loss: 3) - Loss per share amounted to SEK 0.27 (loss: 0.03) - Cash flow during the period was a negative SEK 28 m (negative: 22) - The portfolio company CMA Microdialysis acquired the outstanding shares in the associated company Dipylon Medical - Jointly with Altor Fund III, the portfolio company Bure completed the acquisition of Carnegie Investment Bank and Max Matthiessen from the Swedish National Debt Office Interim report period January – June 2009 - The Group reported an operating loss of SEK 36 m (loss: 3) - After taxes, the Group’s loss was SEK 18 m (profit: 1) - Loss per share amounted to SEK 0.25 (profit: 0.02) - Cash flow during the period amounted to SEK 176 m (negative: 79) - The decline in earnings of the subsidiary MYDATA continued. The operating loss amounted to SEK 69 m, of which losses on currency forward contracts totaled SEK 35 m - The portfolio company Bure completed its redemption program. Skanditek received SEK 201 m After the end of the interim period - Skanditek completed the divestment of the subsidiary MYDATA and became the largest share owner in Micronic Laser Systems, with a 38.0 of the shares